Cite
Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.
MLA
Seo, Hyungil, et al. “Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn’s Disease: A Hospital-Based Cohort Study from Korea.” Digestive Diseases and Sciences, vol. 62, no. 10, Oct. 2017, pp. 2882–93. EBSCOhost, https://doi.org/10.1007/s10620-017-4715-7.
APA
Seo, H., Ye, B. D., Song, E. M., Lee, S.-H., Chang, K., Lee, H.-S., Hwang, S. W., Park, S. H., Yang, D.-H., Kim, K.-J., Byeon, J.-S., Myung, S.-J., & Yang, S.-K. (2017). Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn’s Disease: A Hospital-Based Cohort Study from Korea. Digestive Diseases and Sciences, 62(10), 2882–2893. https://doi.org/10.1007/s10620-017-4715-7
Chicago
Seo, Hyungil, Byong Duk Ye, Eun Mi Song, Sun-Ho Lee, Kiju Chang, Ho-Su Lee, Sung Wook Hwang, et al. 2017. “Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn’s Disease: A Hospital-Based Cohort Study from Korea.” Digestive Diseases and Sciences 62 (10): 2882–93. doi:10.1007/s10620-017-4715-7.